ArticleEuropean radiology2019
Convolutional neural network to predict the local recurrence of giant cell tumor of bone after curettage based on pre-surgery magnetic resonance images.
Article in European radiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed, 3 syntheses or guidelines pooled it, 60 citations in OpenAlex.
- Performance comparison and future perspectives of deep learning and classical machine learning in bone tumor applications: a systematic review (2019-2025).BMC medical informatics and decision making · 2026Pooled it
- The value of artificial intelligence in ultrasound imaging for predicting molecular subtypes of breast cancer: a meta-analysis.Frontiers in oncology · 2026Pooled it
- Artificial intelligence applied to musculoskeletal oncology: a systematic review.Skeletal radiology · 2022Pooled it
- A novel predictive model of microvascular invasion in hepatocellular carcinoma based on differential protein expression.BMC gastroenterology · 2023Trial
- AI in Musculoskeletal Imaging: An End-to-End Perspective.Journal of clinical medicine · 2026Review
- [Artificial intelligence in orthopaedic oncology].Orthopadie (Heidelberg, Germany) · 2026Review
- Research progress of artificial intelligence in bone tumor imaging.Frontiers in oncology · 2026Review
- Artificial Intelligence Applications in Musculoskeletal Imaging.Current reviews in musculoskeletal medicine · 2025Review
- End-to-end deep learning for the diagnosis of pelvic and sacral tumors using non-enhanced MRI: a multi-center study.NPJ precision oncology · 2025Article
- Artificial Intelligence in Surgery: A Systematic Review of Use and Validation.Journal of clinical medicine · 2024Review
- An enhanced AlexNet-Based model for femoral bone tumor classification and diagnosis using magnetic resonance imaging.Journal of bone oncology · 2024Article
- AI applications in musculoskeletal imaging: a narrative review.European radiology experimental · 2024Review
- Deep-learning for automated detection of MSU deposits on DECT: evaluating impact on efficiency and reader confidence.Frontiers in radiology · 2024Article
- Artificial intelligence and machine learning applications for the imaging of bone and soft tissue tumors.Frontiers in radiology · 2024Review
- The promise and limitations of artificial intelligence in musculoskeletal imaging.Frontiers in radiology · 2023Review
- A Survey on Deep Learning for Precision Oncology.Diagnostics (Basel, Switzerland) · 2022Review
- COPD identification and grading based on deep learning of lung parenchyma and bronchial wall in chest CT images.The British journal of radiology · 2022Article
- Transfer learning for medical image classification: a literature review.BMC medical imaging · 2022Review
- Artificial intelligence for MRI diagnosis of joints: a scoping review of the current state-of-the-art of deep learning-based approaches.Skeletal radiology · 2022Article
- Emerging Applications of Deep Learning in Bone Tumors: Current Advances and Challenges.Frontiers in oncology · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 2 institutions in 2 countries.
Funding
Abstract
objectiveTo predict the local recurrence of giant cell bone tumors (GCTB) on MR features and the clinical characteristics after curettage using a deep convolutional neural network (CNN).
methodsMR images were collected from 56 patients with histopathologically confirmed GCTB after curettage who were followed up for 5.8 years (range, 2.0 to 9.5 years). The inception v3 CNN architecture was fine-tuned by two categories of the MR datasets (recurrent and non-recurrent GCTB) obtained through data augmentation and was validated using fourfold cross-validation to evaluate its generalization ability. Twenty-eight cases (50%) were chosen as the training dataset for the CNN and four radiologists, while the remaining 28 cases (50%) were used as the test dataset. A binary logistic regression model was established to predict recurrent GCTB by combining the CNN prediction and patient features (age and tumor location). Accuracy and sensitivity were used to evaluate the prediction performance.
resultsWhen comparing the CNN, CNN regression, and radiologists, the accuracies of the CNN and CNN regression models were 75.5% (95% CI 55.1 to 89.3%) and 78.6% (59.0 to 91.7%), respectively, which were higher than the 64.3% (44.1 to 81.4%) accuracy of the radiologists. The sensitivities were 85.7% (42.1 to 99.6%) and 87.5% (47.3 to 99.7%), respectively, which were higher than the 58.3% (27.7 to 84.8%) sensitivity of the radiologists (p < 0.05).
conclusionThe CNN has the potential to predict recurrent GCTB after curettage. A binary regression model combined with patient characteristics improves its prediction accuracy. KEY POINTS: • Convolutional neural network (CNN) can be trained successfully on a limited number of pre-surgery MR images, by fine-tuning a pre-trained CNN architecture. • CNN has an accuracy of 75.5% to predict post-surgery recurrence of giant cell tumors of bone, which surpasses the 64.3% accuracy of human observation. • A binary logistic regression model combining CNN prediction rate, patient age, and tumor location improves the accuracy to predict post-surgery recurrence of giant cell bone tumors to 78.6%.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.